Literature DB >> 11148249

A prepro-orexin gene polymorphism is associated with narcolepsy.

M Gencik1, N Dahmen, S Wieczorek, M Kasten, J Bierbrauer, I Anghelescu, A Szegedi, A M Menezes Saecker, J T Epplen.   

Abstract

The orexin (hypocretin) neurotransmitter system was recently shown to be directly involved in the pathogenesis of narcolepsy in two animal models. Furthermore, decreased levels of orexin A in the CSF were shown in narcoleptic patients. To define any genetic contribution of orexin to the etiology of narcolepsy, the authors screened the entire prepro-orexin gene for mutations or polymorphisms in 133 patients suffering from narcolepsy. They report an association of a rare polymorphism in the prepro-orexin gene with narcolepsy in a cohort of 178 patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11148249     DOI: 10.1212/wnl.56.1.115

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  What we learned from narcolepsy of others.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2003-02       Impact factor: 4.599

2.  An approach based on a genome-wide association study reveals candidate loci for narcolepsy.

Authors:  Mihoko Shimada; Taku Miyagawa; Minae Kawashima; Susumu Tanaka; Yutaka Honda; Makoto Honda; Katsushi Tokunaga
Journal:  Hum Genet       Date:  2010-07-31       Impact factor: 4.132

3.  Evaluation of polygenic risks for narcolepsy and essential hypersomnia.

Authors:  Maria Yamasaki; Taku Miyagawa; Hiromi Toyoda; Seik-Soon Khor; Xiaoxi Liu; Hitoshi Kuwabara; Yukiko Kano; Takafumi Shimada; Toshiro Sugiyama; Hisami Nishida; Nagisa Sugaya; Mamoru Tochigi; Takeshi Otowa; Yuji Okazaki; Hisanobu Kaiya; Yoshiya Kawamura; Akinori Miyashita; Ryozo Kuwano; Kiyoto Kasai; Hisashi Tanii; Tsukasa Sasaki; Yutaka Honda; Makoto Honda; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2016-06-16       Impact factor: 3.172

4.  Polymorphisms of the tumor necrosis factor receptors: no association with narcolepsy in German patients.

Authors:  Stefan Wieczorek; Norbert Dahmen; Peter Jagiello; Joerg T Epplen; Martin Gencik
Journal:  J Mol Med (Berl)       Date:  2003-02-11       Impact factor: 4.599

5.  Screening for candidate gene regions in narcolepsy using a microsatellite based approach and pooled DNA.

Authors:  Stefan Wieczorek; Peter Jagiello; Larissa Arning; Norbert Dahmen; Joerg T Epplen
Journal:  J Mol Med (Berl)       Date:  2004-08-07       Impact factor: 4.599

6.  Genome-wide analysis of CNV (copy number variation) and their associations with narcolepsy in a Japanese population.

Authors:  Maria Yamasaki; Taku Miyagawa; Hiromi Toyoda; Seik-Soon Khor; Asako Koike; Aino Nitta; Kumi Akiyama; Tsukasa Sasaki; Yutaka Honda; Makoto Honda; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2014-04-03       Impact factor: 3.172

7.  ApoE polymorphisms in narcolepsy.

Authors:  M Gencik; N Dahmen; S Wieczorek; M Kasten; A Gencikova; J T Epplen
Journal:  BMC Med Genet       Date:  2001-08-09       Impact factor: 2.103

Review 8.  Understanding how discrete populations of hypothalamic neurons orchestrate complicated behavioral states.

Authors:  Allison K Graebner; Manasi Iyer; Matthew E Carter
Journal:  Front Syst Neurosci       Date:  2015-08-04

Review 9.  OX1 and OX2 orexin/hypocretin receptor pharmacogenetics.

Authors:  Miles D Thompson; Henri Xhaard; Takeshi Sakurai; Innocenzo Rainero; Jyrki P Kukkonen
Journal:  Front Neurosci       Date:  2014-05-06       Impact factor: 4.677

10.  Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics.

Authors:  Miles D Thompson; Takeshi Sakurai; Innocenzo Rainero; Mary C Maj; Jyrki P Kukkonen
Journal:  Pharmaceuticals (Basel)       Date:  2017-10-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.